Progress in Radiopharmacy: Developments in Nuclear Medicine, cartea 10
Editat de P.H. Cox, Steven J. Mather, C.B. Sampson, C.R. Lazarusen Limba Engleză Hardback – 31 oct 1986
Din seria Developments in Nuclear Medicine
- 5%
Preț: 361.44 lei - 5%
Preț: 376.76 lei - 5%
Preț: 1049.67 lei - 5%
Preț: 362.13 lei - 5%
Preț: 2029.48 lei - 5%
Preț: 362.70 lei - 5%
Preț: 358.39 lei - 5%
Preț: 690.22 lei - 5%
Preț: 683.18 lei - 5%
Preț: 683.87 lei - 5%
Preț: 2047.74 lei - 5%
Preț: 1359.25 lei - 5%
Preț: 687.74 lei - 5%
Preț: 1054.76 lei - 5%
Preț: 687.93 lei - 5%
Preț: 1062.48 lei - 5%
Preț: 357.93 lei - 5%
Preț: 680.90 lei - 5%
Preț: 1052.31 lei - 5%
Preț: 352.03 lei - 5%
Preț: 1055.49 lei - 5%
Preț: 1055.64 lei - 5%
Preț: 1057.37 lei - 5%
Preț: 1053.55 lei - 5%
Preț: 687.41 lei - 5%
Preț: 350.42 lei - 5%
Preț: 365.42 lei - 5%
Preț: 369.27 lei - 5%
Preț: 364.30 lei - 5%
Preț: 357.93 lei
Preț: 3076.55 lei
Preț vechi: 3238.48 lei
-5%
Puncte Express: 4615
Carte tipărită la comandă
Livrare economică 08-22 iulie
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9780898388237
ISBN-10: 0898388236
Pagini: 616
Ilustrații: XII, 616 p.
Dimensiuni: 155 x 235 x 35 mm
Greutate: 1.05 kg
Ediția:1986
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Nuclear Medicine
Locul publicării:Dordrecht, Netherlands
ISBN-10: 0898388236
Pagini: 616
Ilustrații: XII, 616 p.
Dimensiuni: 155 x 235 x 35 mm
Greutate: 1.05 kg
Ediția:1986
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Nuclear Medicine
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
I. Generator Systems for Ultra-Short-Lived Radionuclides.- Generators for ultra-short-lived radionuclides. Their potential and limitations.- The current status of the Os-191?Ir-191m generator.- Pharmaceutical aspects of Krypton-81m generators.- The Yttrium-87/Strontium-87m generator. A new approach to its preparation.- II. Positron Emitting Radiopharmaceuticals.- Positrons from generators.- Production of positron emitting radionuclides using cyclotrons.- III. Radiochemistry.- Cu(I) supported isotopic exchange of arylbound iodide, new future for fast high yield labelling.- Iodine labelled 5-iodo-2-thiouracil as a melanoma seeking agent: a potential drug for diagnosis and treatment.- The synthesis and biodistribution of a radioiodinated GM1 ganglioside derivative.- Advances in radiochemistry of Tc-99m.- New aspects of complexation of technetium with DTPA ligand.- Indium chemistry in radiopharmaceutical development.- New radiohalogenation: an overview.- IV. Recent Developments in Radiopharmacy Practice.- Computers in radiopharmacy.- New developments in radiopharmacy. Dispensing techniques.- Radiopharmacy information and reporting systems. An overview.- Training and education of pharmacists for radiopharmacy.- Quality control of radiopharmaceuticals: Recent developments in analytical techniques.- A multicentre evaluation of techniques for determination of the radiochemical purity of Tc99m-DTPA.- Implications of new imaging techniques for radiopharmacy.- V. Biological Fate of Radiopharmaceuticals.- Biological fate of renal agents.- Tc99m bone seeking phosphate compounds: Studies on in vivo and in vitro behaviour.- Colloids for functional studies of the reticuloendothelial system. Quality control and biological behaviour.- In vivo behaviour of radiopharmaceuticals formyocardial imaging and metabolic studies.- Incorporation dosimetry of I-131-meta-iodobenzylguanidine (I-131-MIBG).- VI. Radionuclides in Drug Formulation Studies.- Radionuclides in drug formulation studies.- Syringe extractables: Effects on radiopharmaceuticals.- Radiolabelled antibodies as radiopharmaceuticals.- The radiolabelling of monoclonal antibodies with In-111 and their application in vivo for detection of thyroid metastases.- Production, quality control and clinical application of In-111-labelled anti-tumour monoclonal antibody.- Characterization of blood-borne radiolabel and detection of anti-mouse IgC antibodies in cancer patients receiving radiolabelled monoclonal antibody for diagnostic immunoscintigraphy.- Protein based radiopharmaceuticals: Applicability of polyacryl-amide gel electrophoresis in the quality control of labelled protein preparation.- VII. Radiopharmaceutical Aerosols.- Inhaled aerosols: Deposition and clearance.- Radioaerosols: Production and characteristics.- Lung perfusion then ventilation using a Tc-99m aerosol: Experiences with a commercial system.- Author index.